Biotechnology company
Appears in 1 story
Developer of DT120, the LSD-based tablet, preparing an FDA filing after three Phase 3 wins
A single dose of LSD has beaten placebo in two late-stage anxiety trials. The tablet, which dissolves under the tongue, cut anxiety scores within two days and held the benefit for 12 weeks. Definium announced the second win on September 14, 2026.
Updated Sep 16
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
